Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 297.7 | 189.5 | 107.1 | 75.5 | 52.1 |
Revenue growth | 57.1% | 77.0% | 41.8% | 44.9% | |
Cost of goods sold | 51.7 | 33.2 | 22.2 | 15.6 | 13.4 |
Gross profit | 245.9 | 156.3 | 84.8 | 59.9 | 38.8 |
Gross margin | 82.6% | 82.5% | 79.2% | 79.3% | 74.4% |
Sales and marketing | 159.4 | 94.4 | 62.8 | 49.7 | 33.8 |
Research and development | 79.3 | 45.7 | 34.5 | 26.0 | 16.1 |
General and administrative | 52.6 | 28.0 | 22.4 | 20.6 | 8.4 |
EBITA | -40.2 | -8.7 | -32.1 | -35.0 | -19.5 |
EBITA margin | -13.5% | -4.6% | -30.0% | -46.4% | -37.5% |
Amortization of intangibles | 5.1 | 3.1 | 2.7 | 1.4 | |
EBIT | -45.3 | -11.8 | -34.8 | -36.5 | -19.5 |
EBIT margin | -15.2% | -6.2% | -32.5% | -48.3% | -37.5% |
Pre-tax income | -64.9 | -14.6 | -33.4 | -36.1 | -19.0 |
Income taxes | 0.2 | 0.2 | 0.2 | 0.0 | 0.3 |
Tax rate | | | | 0.0% | |
Net income | -65.0 | -14.8 | -34.2 | -36.1 | -19.3 |
Net margin | -21.8% | -7.8% | -31.9% | -47.8% | -37.1% |
|
Diluted EPS | ($1.81) | ($0.46) | ($1.67) | ($5.42) | ($3.04) |
Shares outstanding (diluted) | 36.0 | 32.3 | 20.5 | 6.6 | 6.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|